sepiapterin 250 MG Oral Powder
- RxCUI
- 2723069
- RxNorm name
- sepiapterin 250 MG Oral Powder
- Display name
- sepiapterin 250 MG Oral Powder
- Full name
- sepiapterin 250 MG Oral Powder
- Term type
- SCD
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:38:53
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Sephience | SEPIAPTERIN | PTC Therapeutics Inc. | 32ac719c-49f0-4105-9c46-18c19583a5c2 | 2026-04-24 | Warnings, Adverse reactions | 2723069 |
| Sephience | SEPIAPTERIN | allphamed Pharbil Arzneimittel GmbH | 9fabfee2-9488-4d03-b203-8fa50f9a7f55 | 2025-10-02 | Warnings, Adverse reactions | 2723069 |
DailyMed RxNorm Mappings#
| Set ID | RxNorm string | TTY | SPL version | Label | Effective |
|---|---|---|---|---|---|
| 32ac719c-49f0-4105-9c46-18c19583a5c2 | sepiapterin 250 MG Oral Powder | PSN | 6 | These highlights do not include all the information needed to use SEPHIENCE safely and effectively. See full prescribing information for SEPHIENCE. SEPHIENCE (sepiapterin) oral powder Initial U.S. Approval: 2025 | 20260424 |
| 32ac719c-49f0-4105-9c46-18c19583a5c2 | sepiapterin 250 MG Oral Powder | SCD | 6 | These highlights do not include all the information needed to use SEPHIENCE safely and effectively. See full prescribing information for SEPHIENCE. SEPHIENCE (sepiapterin) oral powder Initial U.S. Approval: 2025 | 20260424 |
| 9fabfee2-9488-4d03-b203-8fa50f9a7f55 | sepiapterin 250 MG Oral Powder | PSN | 1 | These highlights do not include all the information needed to use SEPHIENCE safely and effectively. See full prescribing information for SEPHIENCE. SEPHIENCE (sepiapterin) oral powder Initial U.S. Approval: 2025 | 20251002 |
| 9fabfee2-9488-4d03-b203-8fa50f9a7f55 | sepiapterin 250 MG Oral Powder | SCD | 1 | These highlights do not include all the information needed to use SEPHIENCE safely and effectively. See full prescribing information for SEPHIENCE. SEPHIENCE (sepiapterin) oral powder Initial U.S. Approval: 2025 | 20251002 |